Evidence map›Paper›PMID 28522733›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2017

Activation of PERK Elicits Memory Impairment through Inactivation of CREB and Downregulation of PSD95 After Traumatic Brain Injury.

Tanusree Sen, Rajaneesh Gupta, Helen Kaiser, Nilkantha Sen

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 116 citations in OpenAlex.

  1. Distinct cell type-specific mechanisms underlie cognitive dysfunction during persistent integrated stress response activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. ISR Modulators in Neurological Diseases.Current neuropharmacology · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tanusree SenDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, and.
Rajaneesh GuptaDepartment of Neuroscience and Regenerative Medicine, Augusta University, Augusta, Georgia 30907.ORCID 0000-0003-0212-6478
Helen KaiserDepartment of Neuroscience and Regenerative Medicine, Augusta University, Augusta, Georgia 30907.
Nilkantha SenDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, and senn@pitt.edu.
Augusta University · USUniversity of Pittsburgh · US

Funding

Molecular Mechanisms underlying vision impairment after TBIR01EY025622 · NEI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SEN, NILKANTHA · 2016 to 2020
$1.9M
Development of therapeutic strategy against TBI based on hydrogen sulfideR01NS094516 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SEN, NILKANTHA · 2016 to 2020
$1.7M
NEI NIH HHS R01 EY025622NINDS NIH HHS R01 NS094516
6 · The paper itself

Abstract

The PKR-like ER kinase (PERK), a transmembrane protein, resides in the endoplasmic reticulum (ER). Its activation serves as a key sensor of ER stress, which has been implicated in traumatic brain injury (TBI). The loss of memory is one of the most common symptoms after TBI, but the precise role of PERK activation in memory impairment after TBI has not been well elucidated. Here, we have shown that blocking the activation of PERK using GSK2656157 prevents the loss of dendritic spines and rescues memory deficits after TBI. To elucidate the molecular mechanism, we found that activated PERK phosphorylates CAMP response element binding protein (CREB) and PSD95 directly at the S129 and T19 residues, respectively. Phosphorylation of CREB protein prevents its interaction with a coactivator, CREB-binding protein, and subsequently reduces the BDNF level after TBI. Conversely, phosphorylation of PSD95 leads to its downregulation in pericontusional cortex after TBI in male mice. Treatment with either GSK2656157 or overexpression of a kinase-dead mutant of PERK (PERK-K618A) rescues BDNF and PSD95 levels in the pericontusional cortex by reducing phosphorylation of CREB and PSD95 proteins after TBI. Similarly, administration of either GSK2656157 or overexpression of PERK-K618A in primary neurons rescues the loss of dendritic outgrowth and number of synapses after treatment with a PERK activator, tunicamycin. Therefore, our study suggests that inhibition of PERK phosphorylation could be a potential therapeutic target to restore memory deficits after TBI.

Indexed as

AnimalsBrain Injuries, TraumaticCyclic AMP Response Element-Binding ProteinDendritic SpinesDisks Large Homolog 4 ProteinDown-RegulationeIF-2 KinaseEnzyme ActivationGuanylate KinasesMaleMembrane ProteinsMemory DisordersMiceMice, Inbred C57BLCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinDisks Large Homolog 4 ProteinDlg4 protein, mouseeIF-2 KinaseGuanylate KinasesMembrane ProteinsCREBGSK3BPERKPSD95TBI

Identifiers

PMID28522733
PMCPMC5473207
OpenAlexW2614346335

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.